We
outline a simple protocol that accesses directly unprotected
secondary amines by intramolecular C–N bond forming dearomatization
or aryl C–H amination. The method is dependent on the generation
of a potent electrophilic aminating agent released by in situ deprotection
of O-Ts activated N-Boc hydroxylamines.
In situ deprotection (TFA) of O-Ts activated N-Boc hydroxylamines triggers intramolecular aziridination of N-tethered alkenes to provide complex N-heterocyclic ring systems. Synthetic and computational studies corroborate a diastereospecific aza-Prilezhaev-type mechanism. The feasibility of related intermolecular alkene aziridinations is also demonstrated.
Diamine-mediated
α-deprotonation of O-alkyl
carbamates or benzoates with alkyllithium reagents, trapping of the
carbanion with organoboron compounds, and 1,2-metalate rearrangement
of the resulting boronate complex are the primary steps by which organoboron
compounds can be stereoselectively homologated. Although the final
step can be easily monitored by 11B NMR spectroscopy, the
first two steps, which are typically carried out at cryogenic temperatures,
are less well understood owing to the requirement for specialized
analytical techniques. Investigation of these steps by in situ IR
spectroscopy has provided invaluable data for optimizing the homologation
reactions of organoboron compounds. Although the deprotonation of
benzoates in noncoordinating solvents is faster than that in ethereal
solvents, the deprotonation of carbamates shows the opposite trend,
a difference that has its origin in the propensity of carbamates to
form inactive parasitic complexes with the diamine-ligated alkyllithium
reagent. Borylation of bulky diamine-ligated lithiated species in
toluene is extremely slow, owing to the requirement for initial complexation
of the oxygen atoms of the diol ligand on boron with the lithium ion
prior to boron–lithium exchange. However, ethereal solvent,
or very small amounts of THF, facilitate precomplexation through initial
displacement of the bulky diamines coordinated to the lithium ion.
Comparison of the carbonyl stretching frequencies of boronates derived
from pinacol boronic esters with those derived from trialkylboranes
suggests that the displaced lithium ion is residing on the pinacol
oxygen atoms and the benzoate/carbamate carbonyl group, respectively,
explaining, at least in part, the faster 1,2-metalate rearrangements
of boronates derived from the trialkylboranes.
A C−N bond forming dearomatization protocol with broad scope is outlined. Specifically, bifunctional amino reagents are used for sequential nucleophilic and electrophilic C−N bond formations, with the latter effecting the key dearomatization step. Using this approach, γ‐arylated alcohols are converted to a wide range of differentially protected spirocyclic pyrrolidines in just two or three steps.
Dearomatization reactions allow the direct synthesis of structurally complex sp 3 -rich molecules from readily available "flat" precursors. Established dearomatization processes commonly involve the formation of new CÀ C bonds, whereas methods that enable the introduction of CÀ N bonds have received less attention. Because of the privileged position of nitrogen in drug discovery, significant recent methodological efforts have been directed towards addressing this deficiency. Consequently, a variety of new processes are now available that allow the direct preparation of sp 3 -rich amino-containing building blocks and scaffolds. This review gives an overview of CÀ N bond forming dearomatization reactions, particularly with respect to scaffold assembly processes. The discussion gives historical context, but the main focus is on selected methods that have been reported recently.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.